[HTML][HTML] A cost-effectiveness framework for amyotrophic lateral sclerosis, applied to riluzole

NJ Thakore, EP Pioro, BL Udeh, BR Lapin, IL Katzan - Value in Health, 2020 - Elsevier
Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral
sclerosis (ALS) in light of recent advances in disease staging and understanding of stage …

A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole.

NJ Thakore, EP Pioro, BL Udeh, BR Lapin… - Value in Health: the …, 2020 - europepmc.org
Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral
sclerosis (ALS) in light of recent advances in disease staging and understanding of stage …

A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole

NJ Thakore, EP Pioro, BL Udeh, BR Lapin… - Value in …, 2020 - scholars.northwestern.edu
Objectives: Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral
sclerosis (ALS) in light of recent advances in disease staging and understanding of stage …

A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole

NJ Thakore, EP Pioro, BL Udeh… - Value in health: the …, 2020 - pubmed.ncbi.nlm.nih.gov
Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral
sclerosis (ALS) in light of recent advances in disease staging and understanding of stage …

[HTML][HTML] A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole

NJ Thakore, EP Pioro, BL Udeh, BR Lapin… - Value in …, 2020 - valueinhealthjournal.com
Objectives Reexamine cost-effectiveness of riluzole in the treatment of amyotrophic lateral
sclerosis (ALS) in light of recent advances in disease staging and understanding of stage …